Every reason behind the verdict rather than the headline one — which of your certifications match, how much runway is left, whether the work is your size, and what we would need to know to sharpen it.
Written against this notice and what you have told us about your company. Anything we do not know is marked [NEEDS INPUT] in the draft rather than guessed at — read it before you send it.
Start a free trial to draft these. Nothing is sent to an agency on your behalf, ever — you get a document to review, edit and submit yourself.
Sources Sought response
A complete draft response — capability statement, relevant past performance, business size and socioeconomic status, and answers to the agency's specific questions.
Questions to submit
Genuine ambiguities and requirements that disadvantage a smaller bidder, drafted as questions you can submit before the Q&A deadline.
Past performance write-ups
Which of your prior awards best match this requirement, and draft write-ups in the format the agency asked for.
Solicitation details
Solicitation number
S-191192
Notice type
Special Notice
NAICS
541715
Product service code
AJ11
Set-aside
No Set aside used
Posted
2026-06-15
Response deadline
Dec 16, 2026, 12:00 AM UTC
Place of performance
Los Alamos, NM
Contracting contact
licensing@lanl.gov
Market intelligence
Account requiredWho wins this work, and what it pays
Comparable awards under NAICS 541715 at this agency — the incumbent, what they were paid, when their period of performance ends, and the real pricing distribution rather than the headline number. From public federal award records.
The Bacterial Lipid Nanodiscs Platform developed by Los Alamos National Laboratory provides a new way to study entire bacterial membranes in a controlled, nanoscale format derived directly from native lipid extracts. Researchers gain access to membrane components that typically remain difficult to isolate, stabilize or analyze, enabling more accurate evaluation of immunogenic lipids and membrane?associated targets. The platform offers a safer alternative to handling live high?risk pathogens while preserving the biological context that drives meaningful insights for vaccine design and antimicrobial discovery such as therapeutic antibodies to conserved lipids on bacterial membranes. How it Works The Bacterial Lipid Nanodiscs Platform creates uniform nanoscale discs from total lipid extracts harvested from bacterial membranes. Membrane scaffold protein MSP1D1 encases the lipid mixture and forms a stable disc roughly 10 nanometers wide. The resulting particles retain the full complement of native bacterial lipids, arranged in a membrane?like environment that supports realistic biological interactions without requiring synthetic lipids or live cells. Technical Description The method adapts established nanodisc assembly techniques to incorporate entire bacterial lipid extracts rather than defined synthetic lipid mixtures. Total lipids from a pathogen are solubilized, combined with MSP1D1 and dialyzed under controlled conditions to allow the scaffold protein to form a discoidal structure around the heterogeneous lipid population. The process yields nanoparticles that represent the membrane environment of the source organism, including amphiphilic molecules that typically resist purification or structural study when isolated from their native context. The approach was demonstrated using Yersinia pestis, chosen to illustrate how membrane characterization can proceed without the hazards associated with live Tier 1 pathogens. The method captures lipopolysaccharides (LPS) and diverse immunogenic lipids in an arrangement that mirrors their natural organization. Researchers can evaluate binding interactions, immune?stimulating properties and potential antigenic targets in a stable platform that avoids the limitations of outer membrane vesicle purification. Furthermore, using this platform we have identified antibodies specific to E. coli LPS and Y. pestis membrane lipids. These antibodies are independently licensable. Advantages • Provides membrane?like structures using native bacterial lipids • Avoids the safety challenges of handling live pathogens • Offers a broader and more realistic lipid environment than synthetic nanodiscs • Enables improved assessment of membrane antigens and immune responses • Supports analysis of diverse bacterial species using a unified workflow • Creates consistent nanoscale particles suitable for research and development settings Market Applications • Life Sciences Research (membrane biology, immunology) • Vaccine Development (bacterial antigen discovery) • Drug Discovery (membrane?associated targets) • Diagnostics (lipid biomarker exploration) • Biodefense Research (safe pathogen characterization) Development Status: TRL 3 U.S. Patent pending LA-UR-26-24920 LANL Tech Partnerships: Unlock the Innovative Potential Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products. LANL’s licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements. For specific discussions, please contact licensing@lanl.gov. Note: This is not a call for external services for the development of this technology. https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology m.lanl.gov/tech-search
Contact
Point of contact
Caleb Ledgerwood
Role
not stated on this notice — SAM publishes a role for only about 5% of them, so this may be a contract specialist rather than the contracting officer
Email
licensing@lanl.gov
Secondary
licensing@lanl.gov
Submit questions
Ambiguities and requirements worth clarifying, written as questions you can send before the deadline.
Opens in your own mail client, addressed and with a subject line — you write the message. GovSprint never sends anything on your behalf.
Emails open in your mail client and are sent from your address, so the reply comes back to you and the exchange stays yours. Confirm the correct channel and any question deadline on the notice before sending — many solicitations require questions in a specific way.
